54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 28
13:35 UTC
|
MOH
Molina Healthcare
|
◎ Target | Stephen Baxter ★★★★★ #131 | Equal Weight | $235.00→ $220.00-6.4% |
|
Jul 28
13:35 UTC
|
HBAN
Huntington Bancshares
|
◎ Target | Brian Foran ★★★★☆ #821 | Buy | $19.00→ $20.00+5.3% |
|
Jul 28
13:35 UTC
|
HAPN
Lendingclub
|
◎ Target | David M. Scharf not yet tracked | Market Outperform | $23.00→ $25.00+8.7% |
|
Jul 28
13:35 UTC
|
FCNCA
First Citizens BancShares
|
◎ Target | Brian Foran ★★★★☆ #821 | Hold | $2,150.00→ $2,323.00+8.0% |
|
Jul 28
13:35 UTC
|
EGP
EastGroup Properties
|
◎ Target | Michael Lewis ★★★★☆ #800 | Buy | $215.00→ $230.00+7.0% |
|
Jul 28
13:35 UTC
|
CCI
Crown Castle
|
◎ Target | Matthew Niknam ★★★☆☆ #1561 | Hold | $95.00→ $87.00-8.4% |
|
Jul 28
13:35 UTC
|
ARGX
argenex
|
◎ Target | David Nierengarten ★★☆☆☆ #2446 | Outperform | $1,000.00→ $1,050.00+5.0% |
|
Jul 28
13:35 UTC
|
XOM
ExxonMobil
|
↓ Downgrade | Jean Ann Salisbury ★★★★☆ #858 | Buy→ Neutral | $158.00 |
|
Jul 28
13:35 UTC
|
SYRE
Spyre Therapeutics
|
↓ Downgrade | firm only | Outperform→ Peer Perform | |
|
Jul 28
13:35 UTC
|
PODD
Insulet
|
↓ Downgrade | firm only | Buy→ Neutral | $174.00 |
|
Jul 28
13:35 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★★★★ #88 | Buy→ Hold | $304.00 |
|
Jul 28
13:35 UTC
|
INSP
Inspire Medical Systems
|
↓ Downgrade | firm only | Neutral→ Sell | |
|
Jul 28
13:35 UTC
|
GKOS
Glaukos
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jul 28
13:35 UTC
|
FMS
Fresenius Medical Care AG & Co. KGaA
|
↓ Downgrade | firm only | Neutral→ Underperform | $19.90 |
|
Jul 28
13:35 UTC
|
EBC
Eastern Bankshares
|
↓ Downgrade | Matt Breese not yet tracked | Overweight→ Equal Weight | $24.00 |
|
Jul 28
13:35 UTC
|
SOLV
Solventum
|
↑ Upgrade | Kevin Caliendo ★★★★☆ #424 | Neutral→ Buy | $95.00 |
|
Jul 28
13:35 UTC
|
RELL
Richardson Electronics
|
↑ Upgrade | Bobby Brooks ★★★☆☆ #2163 | Market Perform→ Outperform | $24.00 |
|
Jul 28
12:43 UTC
|
WYNN
Wynn Resorts
|
◎ Target | Ben Chaiken not yet tracked | Outperform | $133.00→ $125.00-6.0% |
|
Jul 28
12:43 UTC
|
WSO
Watsco
|
◎ Target | David Manthey ★★★☆☆ #1708 | Outperform | $460.00→ $420.00-8.7% |
|
Jul 28
12:43 UTC
|
WCN
Waste Connections
|
◎ Target | William Grippin ★★★☆☆ #2173 | Equal Weight | $180.00→ $187.00+3.9% |
|
Jul 28
12:43 UTC
|
VVV
Valvoline
|
◎ Target | Thomas Wendler ★★★☆☆ #1237 | Overweight | $44.00→ $48.00+9.1% |
|
Jul 28
12:43 UTC
|
UHS
Universal Health Services
|
◎ Target | Andrew Mok not yet tracked | Equal Weight | $179.00→ $168.00-6.1% |
|
Jul 28
12:43 UTC
|
TWLO
Twilio
|
◎ Target | Nick Altmann ★★★★★ #307 | Buy | $215.00→ $245.00+14.0% |
|
Jul 28
12:43 UTC
|
TREX
Trex
|
◎ Target | Trey Grooms ★★★☆☆ #1694 | Equal Weight | $45.00→ $50.00+11.1% |
|
Jul 28
12:43 UTC
|
TLN
Talen Energy
|
◎ Target | Nicholas Campanella ★★★☆☆ #1618 | Overweight | $411.00→ $408.00-0.7% |
|
Jul 28
12:43 UTC
|
THC
Tenet Healthcare
|
◎ Target | Jason Cassorla ★★★★☆ #342 | Buy | $242.00→ $283.00+16.9% |
|
Jul 28
12:43 UTC
|
THC
Tenet Healthcare
|
◎ Target | Michael Ha ★★★★★ #228 | Neutral | $210.00→ $280.00+33.3% |
|
Jul 28
12:43 UTC
|
SSD
Simpson Manufacturing
|
◎ Target | Trey Grooms ★★★☆☆ #1694 | Equal Weight | $210.00→ $215.00+2.4% |
|
Jul 28
12:43 UTC
|
SITE
SiteOne Landscape Supply
|
◎ Target | David Manthey ★★★☆☆ #1708 | Outperform | $160.00→ $155.00-3.1% |
|
Jul 28
12:43 UTC
|
SHBI
Shore Bancshares
|
◎ Target | Catherine Mealor ★★★★☆ #387 | Market Perform | $22.00→ $25.00+13.6% |
|
Jul 28
12:43 UTC
|
QTTB
Q32 Bio
|
◎ Target | Joseph Pantginis ★★☆☆☆ #2813 | Buy | $13.00→ $36.00+176.9% |
|
Jul 28
12:43 UTC
|
NTST
NETSTREIT
|
◎ Target | Jay Kornreich ★★★★☆ #773 | Overweight | $24.00→ $25.00+4.2% |
|
Jul 28
12:43 UTC
|
NRG
NRG Energy
|
◎ Target | Nicholas Campanella ★★★☆☆ #1618 | Overweight | $200.00→ $204.00+2.0% |
|
Jul 28
12:43 UTC
|
NEM
Newmont
|
◎ Target | Richard Garchitorena ★★★☆☆ #2261 | Overweight | $125.00→ $124.00-0.8% |
|
Jul 28
12:43 UTC
|
NBBK
NB Bancorp
|
◎ Target | David Konrad ★★★★★ #194 | Market Perform | $24.00→ $25.00+4.2% |
|
Jul 28
12:43 UTC
|
MTDR
Matador Resources
|
◎ Target | Mike Scialla not yet tracked | Overweight | $92.00→ $93.00+1.1% |
|
Jul 28
12:43 UTC
|
MPLT
Maplight Therapeutics
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $45.00→ $26.00-42.2% |
|
Jul 28
12:43 UTC
|
LW
Lamb Weston
|
◎ Target | Pooran Sharma ★★★☆☆ #1812 | Equal Weight | $46.00→ $55.00+19.6% |
|
Jul 28
12:43 UTC
|
LADR
Ladder Capital
|
◎ Target | Jade Rahmani ★★★☆☆ #1699 | Outperform | $11.00→ $10.75-2.3% |
|
Jul 28
12:43 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Brad Canino not yet tracked | Buy | $125.00→ $135.00+8.0% |
|
Jul 28
12:43 UTC
|
KFRC
Kforce
|
◎ Target | Mark Marcon ★★★★★ #6 | Outperform | $42.00→ $63.00+50.0% |
|
Jul 28
12:43 UTC
|
JLL
Jones Lang LaSalle
|
◎ Target | Brendan Lynch ★★★☆☆ #1532 | Equal Weight | $366.00→ $368.00+0.5% |
|
Jul 28
12:43 UTC
|
JHX
James Hardie Industries
|
◎ Target | Trey Grooms ★★★☆☆ #1694 | Overweight | $31.00→ $33.00+6.5% |
|
Jul 28
12:43 UTC
|
HIG
The Hartford Insurance Group
|
◎ Target | Meyer Shields ★★★★★ #140 | Market Perform | $143.00→ $144.00+0.7% |
|
Jul 28
12:43 UTC
|
HFWA
Heritage Financial
|
◎ Target | Andrew Terrell ★★★★☆ #557 | Equal Weight | $30.00→ $32.00+6.7% |
|
Jul 28
12:43 UTC
|
HCA
HCA Healthcare
|
◎ Target | Ann Hynes ★★★★★ #9 | Outperform | $525.00→ $475.00-9.5% |
|
Jul 28
12:43 UTC
|
HBT
HBT Financial
|
◎ Target | Damon Delmonte ★★★★★ #103 | Outperform | $34.00→ $38.00+11.8% |
|
Jul 28
12:43 UTC
|
FROG
JFrog
|
◎ Target | Nick Altmann ★★★★★ #307 | Buy | $80.00→ $100.00+25.0% |
|
Jul 28
12:43 UTC
|
FRMI
Fermi
|
◎ Target | Vikram Malhotra ★★★☆☆ #1398 | Outperform | $27.00→ $11.00-59.3% |
|
Jul 28
12:43 UTC
|
FLUT
Flutter Entertainment
|
◎ Target | Clark Lampen ★★☆☆☆ #2437 | Buy | $126.00→ $120.00-4.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.